Fatemeh Chalabianloo
Bergen, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Strengthening global responses to stimulant use disorders: From policy commitments to evidence-based treatment innovation.
Journal: Addiction (Abingdon, England)
Published: June 06, 2026
ADHD, substance use and psychotic disorders
Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke
Published: March 27, 2026
Association between thyroidea function and opioid agonist therapy: a prospective cohort study from Norway.
Journal: Journal of the Endocrine Society
Published: August 13, 2025
Low Testosterone Among Males in Opioid Agonist Therapy and Its Association With Fatigue and Psychological Distress.
Journal: Journal of the Endocrine Society
Published: February 27, 2025
Integrated Nicotine Replacement and Behavioral Support to Reduce Smoking in Opioid Agonist Therapy: A Randomized Clinical Trial.
Journal: JAMA psychiatry
Published: February 12, 2025
The effect of fruit smoothie supplementation on psychological distress and biomarkers among people with opioid dependence receiving opioid agonist therapy: a randomized controlled trial.
Journal: BMC medicine
Published: January 03, 2025
Methadone metabolism and cytochrome P450 polymorphisms: a systematic review and meta-analysis.
Journal: Expert opinion on drug metabolism & toxicology
Published: November 28, 2024
Prevalence of substance use disorder in individuals with attention deficit/hyperactivity disorder: associations with sex and psychiatric comorbidity.
Journal: BMC psychiatry
Published: September 29, 2024
Universal Health Coverage of Opioid Agonist Treatment in Norway: An Equity-Adjusted Economic Evaluation.
Journal: PharmacoEconomics
Published: September 26, 2024
Associations between happiness with social factors and opioid agonist therapy among people who inject drugs.
Journal: Scientific reports
Published: November 26, 2023
Last Updated: 09/26/2026